J, Z., S, H., J, T., Y, L., & D, H. (2023). Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press.
Chicago-referens (17:e uppl.)J, Zhao, Hao S, Tian J, Li Y, och Han D. Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press, 2023.
MLA-referens (9:e uppl.)J, Zhao, et al. Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study. Dove Medical Press, 2023.